Ionis Pharmaceuticals | IONS - PE价格收益



金融业
股票价格
USD
资产
USD 2.99B
现金及等价物
USD 350.07M
销售成本
USD 2.74M
流动资产
USD 2.49B
流动负债
USD 315.64M
债务
USD 1.91B
EBIT
USD -102.29M
EBITDA
USD -64.53M
员工
1.07K
EPS每股收益
USD -0.69
股本和储备
USD 439.74M
销售毛利
USD 265M
债务利息支出
USD 18M
利息收入
USD -0.66
贷款资金
USD 1.91B
市值
USD 8.86B
净收入
USD -114.65M
营业费用
USD 370.24M
营业利润
USD -102.29M
普通股股本
USD 165.64M
PE价格收益
396.15
税前利润
USD -114M
销售收入
USD 268M
销售和管理费用
USD 130.08M
股票
USD 50.83M
贸易债权人
USD 47.7M
应收帐款人
USD 58.85M


Pe 更改 日
Agios Pharmaceuticals 3.56 0 2026-03
Alnylam Pharmaceuticals 75.64 4.4 2026-06
Arrowhead Research 39.19 0 2026-06
Astellas Pharma 9.41 6.06 2026-06
BioCryst Pharmaceuticals 6.84 0.78 2026-06
BioMarin Pharmaceutical 21.07 5.79 2026-06
Celltrion 58.97 8.86 2026-03
Cspc Pharmaceutical 23.62 0.78 2026-03
Deva Holding AS 6.55 2.01 2023-09
Divis Laboratories Ltd 58.35 1.4 2026-06
Exelixis 18.02 4.11 2026-06
Halozyme Therapeutics 12.51 1.15 2026-06
Ionis Pharmaceuticals 396.15 79.28 2022-09
Kangmei Pharma 1.11K 2.04K 2026-03
Knight Therapeutics 257.34 166.24 2025-12
Laboratorios Farma 18.78 6.64 2023-12
Malin Corporation 11.81 0.72 2023-06
Moderna 27.22 14.51 2023-06
Neuren Pharmaceuticals 72.14 59.86 2025-12
Neurocrine Biosciences 22.1 5.99 2026-06
Novartis 22.41 2.24 2026-06
OPKO Health 40.77 7.86 2021-09
Organigram Holdings 12.01 222.99 2026-03
Ovoca Bio 1.83 3.29 2024-06
Pfizer 11.48 2.16 2026-06
Pharma Mar 16.35 2.78 2026-06
PTC Therapeutics 8.76 1.22 2026-03
Qiagen NV 16.72 2.76 2026-06
Regeneron Pharmaceuticals 15.46 9.68 2026-06
Roche Holding 16.48 0.39 2026-06
Sarepta Therapeutics 27.27 0 2026-03
Sartorius 52.99 9.56 2026-06
Sino Biopharmaceutical 17.03 0.89 2025-06
Tilray 11.56 80.19 2025-09
Vertex Pharmaceuticals 28.05 2.22 2026-06
Zealand Pharma A/S 3.27 1.86 2026-03
Zz Pientze Pharmaceu 47.68 1.35 2026-03